IP Verse

Assay For Jc Virus Antibodies - EP4152004

The patent EP4152004 was granted to Biogen MA on Apr 9, 2025. The application was originally filed on Jan 11, 2011 under application number EP22191259A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4152004

BIOGEN MA
Application Number
EP22191259A
Filing Date
Jan 11, 2011
Status
Granted And Under Opposition
Oct 18, 2024
Grant Date
Apr 9, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

POLPHARMA BIOLOGICSAug 19, 2025ADMISSIBLE

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS3817837
DESCRIPTIONUS3850752
DESCRIPTIONUS3939350
DESCRIPTIONUS3996345
DESCRIPTIONUS4275149
DESCRIPTIONUS4277437
DESCRIPTIONUS4366241
OPPOSITIONWO2007100770
OTHERWO2011085369
SEARCHUS6238859

Non-Patent Literature (NPL) Citations (24) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- EGLI et al., J. Infect. Dis., (20090000), vol. 199, pages 837 - 846-
DESCRIPTION- PICCINNI et al., "Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents", Eur. J. Clin. Pharmacol., (20100000), vol. 66, pages 199 - 206, XP019778034-
DESCRIPTION- PADGETTWALKER, "Prevalence of antibodies in human sera agains JC virus, an isolate from a case of progressive multifocal leukoencephalopathy", J. Infect. Dis., (19730000), vol. 127, doi:10.1093/infdis/127.4.467, pages 467 - 70, XP009171995
DESCRIPTION- MAJOR, "Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory Therapies", Annu. Rev. Med., (20090831), vol. 61, doi:10.1146/annurev.med.080708.082655, pages 35 - 47, XP055162302
OPPOSITION- Bubb M. O., T. Marimuthu, J.D. Conradie, "Hepatitis B surface antigen in donated blood — screening and confirmation by enzyme-linked immunosorbent assay", SA MEDIESE TYDSKRIF / SA Medical Journal, (19830129), vol. 63, pages 148 - 151, XP093308229-
OPPOSITION- Carson, K.R. ; Focosi, D. ; Major, E.O. ; Petrini, M. ; Richey, E.A. ; West, D.P. ; Bennett, C.L., "Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project", The Lancet Oncology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20090801), vol. 10, no. 8, pages 816 - 824, XP026393894-
OPPOSITION- D11 - Expert declaration by Sam Scrimshaw including the Exhibits cited therein-
OPPOSITION- Viscidi Raphael P., Barbara Clayman, "Serological Cross Reactivity between Polyomavirus Capsids", Polyomavirus and human diseases Chapter 5, (20060202), pages 73 - 84, XP093097121-
OPPOSITION- Leonid Gorelik, Michaela Lerner, Sarah Bixler, Mary Crossman, Brian Schlain, Kenneth Simon, Amy Pace, Anne Cheung, Ling Ling Chen, Melissa Berman, Fairuz Zein, Ewa Wilson, Ted Yednock, Alfred Sandrock, Susan E. Goelz, Meena Subramanyam, "Anti-JC virus antibodies: Implications for PML Risk Stratification", Annals of Neurology, Wiley-Liss., (20100901), vol. 68, no. 3, doi:10.1002/ana.22128, ISSN 03645134, pages 295 - 303, XP055136721
OPPOSITION- Adrian Egli, Laura Infanti, Alexis Dumoulin, Andreas Buser, Jacqueline Samaridis, Christine Stebler, Rainer Gosert, Hans h. Hirsch, "Prevalence of Polyomavirus BK and JC Infection and Replication in 400 Healthy Blood Donors", Journal of Infectious Diseases, Oxford University Press, (20090315), vol. 199, no. 6, doi:10.1086/597126, ISSN 0022-1899, pages 837 - 846, XP055491320
OPPOSITION- R. P. Viscidi, D. E. M. Rollison, E. Viscidi, B. Clayman, E. Rubalcaba, R. Daniel, E. O. Major, K. V. Shah, "Serological Cross-Reactivities between Antibodies to Simian Virus 40, BK Virus, and JC Virus Assessed by Virus-Like-Particle-Based Enzyme Immunoassays", Clinical and Vaccine Immunology, American Society for Microbiology, (20030301), vol. 10, no. 2, doi:10.1128/CDLI.10.2.278-285.2003, ISSN 15566811, pages 278 - 285, XP055162298
OPPOSITION- N. Khanna, M. Wolbers, N. J. Mueller, C. Garzoni, R. A. Du Pasquier, C. A. Fux, P. Vernazza, E. Bernasconi, R. Viscidi, M. Battegay, H. H. Hirsch, "JC Virus-Specific Immune Responses in Human Immunodeficiency Virus Type 1 Patients with Progressive Multifocal Leukoencephalopathy", Journal of Virology, American Society for Microbiology., (20090501), vol. 83, no. 9, doi:10.1128/JVI.02657-08, ISSN 0022538X, pages 4404 - 4411, XP055133530
OPPOSITION- Dana E. Rollison, Eric A. Engels, Neal A. Halsey, Keerti V. Shah, Raphael P. Viscidi, Kathy J. Helzlsouer, "Prediagnostic circulating antibodies to JC and BK human polyomaviruses and risk of non-Hodgkin lymphoma.", Cancer epidemiology, biomarkers & prevention, American Association for Cancer Research, (20060301), vol. 15, no. 3, doi:10.1158/1055-9965.EPI-05-0728, ISSN 1055-9965, pages 543 - 550, XP002711818
OPPOSITION- Wright P F, Nilsson E, Van Rooij E M A, Lelenta M, Jeggo M H, "Standardisation and validation of enzymelinked immunosorbent assay techniques for the detection of antibody in infectious disease diagnosis", (19930601), vol. 12, no. 2, doi:10.20506/rst.12.2.691, pages 435 - 450, XP093308231
OPPOSITION- Berger Joseph R., Houff Sidney A., Major Eugene O., "Monoclonal antibodies and progressive multifocal leukoencephalopathy", mAbs, Landes Bioscience, US, US , (20091101), vol. 1, no. 6, doi:10.4161/mabs.1.6.9884, ISSN 1942-0862, pages 583 - 589, XP093130366
OTHER- Viscidi Raphael P., Barbara Clayman, "Serological Cross Reactivity between Polyomavirus Capsids", Viscidi Raphael P., Barbara Clayman, AHSAN. Nasimul, Polyomavirus and human diseases Chapter 5, (20060202), vol. 577, pages 73 - 84, XP093097121-
OTHER- Leonid Gorelik, Michaela Lerner, Sarah Bixler, Mary Crossman, Brian Schlain, Kenneth Simon, Amy Pace, Anne Cheung, Ling Ling Chen, Melissa Berman, Fairuz Zein, Ewa Wilson, Ted Yednock, Alfred Sandrock, Susan E. Goelz, Meena Subramanyam, "Anti-JC virus antibodies: Implications for PML Risk Stratification", Annals of Neurology, (20100901), vol. 68, no. 3, doi:10.1002/ana.22128, ISSN 03645134, pages 295 - 303, XP055136721
OTHER- Kenneth L. Tyler, "Progressive multifocal leukoencephalopathy: Can we reduce risk in patients receiving biological immunomodulatory therapies?", Annals of Neurology, Boston , US , (20100831), vol. 68, no. 3, doi:10.1002/ana.22185, ISSN 0364-5134, pages 271 - 274, XP071639310
SEARCH- GOLDMANN C ET AL, "Molecular cloning and expression of major structural protein VP1 of the human polyomavirus JC virus: formation of virus-like particles useful for immunological and therapeutic studies.", JOURNAL OF VIROLOGY MAY 1999, (199905), vol. 73, no. 5, ISSN 0022-538X, pages 4465 - 4469, XP002711817 [A] 1-18 * abstract, page 4465, left-hand column. *-
SEARCH- KNOWLES W A ET AL, "The JC virus antibody response in serum and cerebrospinal fluid in progressive multifocal leucoencephalopathy.", CLINICAL AND DIAGNOSTIC VIROLOGY AUG 1995, (199508), vol. 4, no. 2, ISSN 0928-0197, pages 183 - 194, XP008130197 [A] 1-18 * abstract *
SEARCH- VAN ASSCHE GERT ET AL, "Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease", NEW ENGLAND JOURNAL OF MEDICINE, THE -, MASSACHUSETTS MEDICAL SOCIETY, US, (20050728), vol. 353, no. 4, doi:10.1056/NEJMOA051586, ISSN 1533-4406, pages 362 - 368, XP009123817 [A] 1-18 * the whole document *
SEARCH- WEBER T ET AL, "Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy.", THE JOURNAL OF INFECTIOUS DISEASES JUL 1997, (199707), vol. 176, no. 1, ISSN 0022-1899, pages 250 - 254, XP002711820 [A] 1-18 * abstract, page 251, left-hand column.; figures 1, 2 *
SEARCH- R. P. VISCIDI ET AL, "Serological Cross-Reactivities between Antibodies to Simian Virus 40, BK Virus, and JC Virus Assessed by Virus-Like-Particle-Based Enzyme Immunoassays", CLINICAL AND VACCINE IMMUNOLOGY, (20030301), vol. 10, no. 2, doi:10.1128/CDLI.10.2.278-285.2003, ISSN 1556-6811, pages 278 - 285, XP055162298 [A] 1-18 * abstract *
SEARCH- ROLLISON DANA E ET AL, "Prediagnostic circulating antibodies to JC and BK human polyomaviruses and risk of non-Hodgkin lymphoma.", CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION : A PUBLICATION OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, COSPONSORED BY THE AMERICAN SOCIETY OF PREVENTIVE ONCOLOGY MAR 2006, (200603), vol. 15, no. 3, ISSN 1055-9965, pages 543 - 550, XP002711818 [A] 1-18 * abstract, page 544, right-hand column, section "laboratory methods. *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents